Antitrust Guidelines News Today

China Office of Inter-Ministerial Joint Meeting for the Building of a Powerful Intellectual Property IP Nation to promotes construction of powerful IP country in 202

With minimal fanfare on a quiet summer Friday afternoon, the Federal Trade Commission (FTC) did what many have been expecting it to do for several months: it officially withdrew from...

WASHINGTON (Reuters) -U.S. antitrust regulators published guidelines on Wednesday on the kinds of mergers and acquisitions they object to, reaffirming the skepticism with which President Joe Biden's administration has approached many deals, especially in the technology sector. The U.S. Justice Department and Federal Trade Commission (FTC) have mounted an unprecedented number of legal challenges to mergers since Biden came to office in 2021. Their success in court has been mixed, with two ...

Antitrust Legislation The Implementation Opinions of Haidian District of Beijing Municipality on Further Promoting Fair Competition Reviews Issued On May 19, 2023, the General Office of the Peoples Government of Haidian District of Beijing Municipality ...

DOJ withdrew 3 policy statements about conduct in the healthcare sector. It is likely the DOJ will engage in a case by case analysis of information exchanges moving forward. The 2000 joint FTC and DOJ Antitrust Guidelines for Collaborations Among Competitors is still in effect.

On February 3, 2023, the Antitrust Division of the Department of Justice (DOJ) withdrew its nearly 30-year-old guidance on information exchanges in the healthcare industry...

On February 3, 2023, the Antitrust Division of the Department of Justice (DOJ) withdrew its nearly 30-year-old guidance on information exchanges in the healthcare industry, including...

The Department of Justice (DOJ) Antitrust Division recently withdrew three sets of policy statements regarding the US antitrust agencies' enforcement approach to conduct in the healthcare industry...

On Friday, February 3, DOJ announced in a press release that it has withdrawn support for three joint DOJ-FTC policy statements that explicitly describe certain "safety zones" applicable to information sharing among competitors.

Late last week, the U.S. Department of Justice Antitrust Division announced its withdrawal of a string of healthcare enforcement policy statements issued in 1993, 1996, and 2011.